AKTX
Akari Therapeutics
AKTX • NASDAQ
Akari Therapeutics is a pharmaceutical preparations company trading on NASDAQ, led by CEO Abizer Gaslightwala.
CEOAbizer Gaslightwala
Next Earnings
Upcoming earnings announcement for Akari Therapeutics
Date
Wednesday, April 15, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.06
Earnings History
Past 12 earnings reports for Akari Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | $0.00Est: -$0.11 | +100.0% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | $0.00Est: -$0.12 | +100.0% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | $0.00 | — | - | — | 10-Q |
| Apr 16, 2025 | Q4 2024 | $0.00 | — | - | — | 10-K |
| Nov 19, 2024 | Q3 2024 | $0.00 | — | - | — | 10-Q |
| Aug 19, 2024 | Q2 2024 | $0.00 | — | - | — | 10-Q |
| May 16, 2024 | Q1 2024 | $0.00 | — | - | — | 10-Q |
| Apr 1, 2024 | FY 2023 | $0.00 | — | - | — | 10-K |
| Sep 29, 2023 | H1 2023 | $0.00 | — | - | — | — |
| May 1, 2023 | FY 2022 | $0.00 | — | - | — | — |
| Sep 27, 2022 | Q2 2022 | -$2.00 | — | - | — | — |
| Jul 20, 2022 | Q1 2022 | $0.00 | — | - | — | — |